Insider Transactions in Q1 2021 at Relmada Therapeutics, Inc. (RLMD)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Jan 26 2021	Paul Edward Kelly Director	SELL Open market or private sale	Direct	685 -0.46%	$23,975 $35.16 P/Share
Jan 25 2021	Maged Shenouda Chief Financial Officer	SELL Open market or private sale	Direct	1,280 -31.11%	$44,800 $35.27 P/Share
Jan 25 2021	Sergio Traversa Chief Executive Officer	SELL Open market or private sale	Direct	1,300 -1.68%	$45,500 $35.29 P/Share
Jan 25 2021	Paul Edward Kelly Director	SELL Open market or private sale	Direct	1,300 -0.87%	$45,500 $35.27 P/Share
Jan 22 2021	Maged Shenouda Chief Financial Officer	SELL Open market or private sale	Direct	2,113 -18.2%	$73,955 $35.78 P/Share
Jan 22 2021	Maged Shenouda Chief Financial Officer	BUY Exercise of conversion of derivative security	Direct	4,000 +39.11%	$1,296,000 $324.0 P/Share
Jan 22 2021	Sergio Traversa Chief Executive Officer	SELL Open market or private sale	Direct	2,170 -1.37%	$75,950 $35.8 P/Share
Jan 22 2021	Sergio Traversa Chief Executive Officer	BUY Exercise of conversion of derivative security	Direct	4,070 +4.87%	$12,210 $3.24 P/Share
Jan 22 2021	Paul Edward Kelly Director	SELL Open market or private sale	Direct	2,100 -0.69%	$3,756,900 $1789.59 P/Share
Jan 22 2021	Paul Edward Kelly Director	BUY Exercise of conversion of derivative security	Direct	4,085 +2.63%	$12,255 $3.24 P/Share
Jan 04 2021	Charles J Casamento Director	SELL Open market or private sale	Direct	3,000 -12.02%	$96,000 $32.11 P/Share

Receive a notification when an Institution or Guru buys or sells RLMD shares.

Notify only if

Value

Get notified when an Relmada Therapeutics, Inc. insider buys or sells RLMD shares.

Notify only if

Operation

Value

Type

Receive news related to RELMADA THERAPEUTICS, INC.